Сообщения

hospitals in us

Изображение
When public refer to today’s medicine, accuracy plays one of the most crucial roles and people’s lives are directly dependent on it. Hereby, any researches pertaining to medicine are necessary to meet the top standards. The challenge nowadays is that any recommendations of researches can be published online and used as a reference without being properly verified and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this challenge and attempted to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The key principle of this journal is based on Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with corresponding scores above 100 as well as repo

Trending with Impact: Basal Cell Bladder Cancer and MEK Inhibitors

For patients with basal cell bladder cancer, researchers in this study identify MEK inhibitors as a viable therapeutic option. 3d Illustration - Bladder cancer cells 3d Illustration – Bladder cancer cell The Trending with Impact series highlights publications attracting higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news and articles about the latest trending publications here and at Oncotarget.com. — oncotarget submission “Basal bladder cancer is frequently clinically aggressive and has the worst overall prognosis [3], and thus, additional therapeutic options for these tumors would be highly clinically relevant.” In this paper published by Oncotarget, researchers from the University of Michigan conducted a study emphasizing the importance of 3D culture screenings versus 2D, and the use of MEK inhibitors to target basal cell bladder cancer. This paper concludes that basal cell blad

hospitals in us

Изображение
When people speak of today’s medicine, precision plays one of the most significant roles and human lives are directly dependent on it. Hence, any researches pertaining to medicine are required to comply with the top standards. The issue nowadays is that any recommendations of researches can be posted online and used as a reference without being adequately verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality indicator. That allows both readers and authors to quality-check publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website demonstrates a complete publications list with respective scores h

MRI and ADC Histogram Analysis in Lymphoma Treatment

Study demonstrates that MRI and DWI of patient samples with primary central nervous system lymphoma can be used to predict and monitor disease progression through the use of ADC histogram analysis of Ki-67 expression. oncotarget research Virus cells under the microscope isolated on white background. Scientists have long been aware that lymphoma occurs when multiple genetic changes take place in the white blood cells. This causes the white blood cells to grow out of control and no longer respond to central signaling—which would stop them from overgrowing and aid in natural cell death. However, many other factors driving lymphoma diagnosis have not been fully illuminated. “Primary central nervous system lymphoma (PCNSL) is a rare subgroup of non-Hodgkin lymphoma confined to the central nervous system, with more than 90% of cases classified as Diffuse Large B-cell Lymphoma [1, 2].” “Oncotarget” In a paper published in Oncotarget, researchers from the United States’ Texas, Missouri,

hospitals in us

Изображение
When public refer to contemporary medicine, precision plays one of the most significant roles and human lives are directly dependent on it. Hereby, any researches related to medicine are necessary to meet the top standards. The problem today is that any recommendations of researches can be shared online and used as a reference without being adequately verified and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and decided to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a full publications list with corresponding scores higher than 100 as we

us clinics lists

Изображение
When people speak of modern medicine, accuracy plays one of the most important roles and people’s lives are literally dependent on it. Hence, any researches pertaining to medicine are required to comply with the highest standards. The challenge nowadays is that any conclusions of researches can be posted online and used as a reference without being precisely checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this issue and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The major principle of this journal is based on Altmetric scores that are used as a quality indicator. That allows both readers and authors to verify publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication. ” Oncotarget website demonstrates a complete publications list with respective scores above

Symmetrically Dividing Prostate Cancer Cells Drive Exponential Growth

Researchers in this study use scaling analysis to show that, in patients with prostate cancer who must be administered different treatments, drug resistant and metastasis-causing cells often emerge and are responsible for producing multi-drug resistant, exponentially growing tumors. Oncotarget’s Listen to an audio version of this article Thirteen percent of men in the United States are diagnosed with prostate cancer at some point in their lifetime, and as many as two to three percent die due to this disease. These highly unfavorable statistics regularly motivate researchers around the world to seek new discoveries and interventions to better understand and restrain prostate cancer. A team of U.S. researchers, from Johns Hopkins University in Maryland, the National Science Foundation in Virginia, Jackson Memorial Hospital in Florida, and Columbia University Irving Medical Center and the James J. Peters Veterans Affairs Medical Center in New York, authored a stu